Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Daniel Bichon is active.

Publication


Featured researches published by Daniel Bichon.


Life Sciences | 1994

SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor.

X. Emonds-Alt; Daniel Bichon; Jean-Philippe Ducoux; Michel Héaulme; B. Miloux; Martine Poncelet; Vincenzo Proietto; D. Van Broeck; P. Vilain; Gervais Neliat; P. Soubrié; G. Le Fur; J.C. Brele`ere

SR 142801 is the first potent and selective non-peptide antagonist of the tachykinin NK3 receptor. It inhibited [MePhe7]NKB binding to its receptor from various species, including humans. SR 142801 was a competitive antagonist of [MePhe7]NKB-mediated contractions of guinea-pig ileum and inhibited the acetylcholine release following the activation of the guinea-pig ileum tachykinin NK3 receptor. In vivo, SR 142801 potently inhibited the turning behaviour induced by intrastriatal injection of senktide in gerbils, and appears as a powerful tool for investigation of the physiological and pathological role of NKB and its NK3 receptor.


European Journal of Pharmacology | 1993

In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist.

Xavier Emonds-Alt; Jean-Daniel Doutremepuich; Michel Héaulme; Gervais Neliat; Vincent Santucci; Régis Steinberg; P. Vilain; Daniel Bichon; Jean-Philippe Ducoux; Vincenzo Proietto; Didier Van Broeck; Philippe Soubrie; Gérard Le Fur; Jean-Claude Breliere


Archive | 1995

Novel N-(3,4-dichlorophenyl-propyl)-piperidine derivatives as selective human NK3-receptor antagonists

Daniel Bichon; Broeck Didier Van; Vincenzo Proietto; Patrick Gueule; Xavier Emonds-Alt


Archive | 1999

Compounds which are selective antagonists of the human nk3 receptor and their use as medicinal products and diagnostic tools

Daniel Bichon; Patrick Gueule; Didier Van Broeck; Xavier Emonds-Alt; Vincenzo Proietto


Archive | 1996

Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them

Daniel Bichon; Xavier Emonds-Alt; Patrick Gueule; Vincenzo Proietto; Didier Van Broeck


Archive | 1996

Human NK3 receptor-selective antagonist compounds, process for their obtention and pharmaceutical compositons containing them

Daniel Bichon; Xavier Edmonds-Alt; Patrick Gueule; Vincenzo Proietto; Broeck Didier Van


Archive | 1996

1-acyl-3-phenyl-3-(3-piperidinopropyl)piperidinderivate als für den menschlichen nk3-rezeptor selektive antagonisten 1-acyl-3-phenyl-3- (3-piperidinopropyl) piperidine derivatives as antagonists of the human NK3 receptor selective

Daniel Bichon; Xavier Edmonds-Alt; Patrick Gueule; Vincenzo Proietto; Broeck Didier Van


Archive | 1996

1-acyl-3-phenyl-3-(3-piperidinopropyl)piperidine derivatives as human nk3 receptor selective antagonists

Daniel Bichon; Xavier Edmonds-Alt; Patrick Gueule; Vincenzo Proietto; Broeck Didier Van


Archive | 1996

Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant

Daniel Bichon; Xavier Edmonds-Alt; Patrick Gueule; Vincenzo Proietto; Broeck Didier Van


Archive | 1996

1-acyl-3-phenyl-3-(3-piperidinopropyl)piperidin-derivate als für den menschlichen nk3-rezeptor selektive antagonisten Piperidine derivatives as antagonists of the human NK3 receptor selective 1-acyl-3-phenyl-3- (3-piperidinopropyl)

Daniel Bichon; Xavier Edmonds-Alt; Patrick Gueule; Vincenzo Proietto; Broeck Didier Van

Collaboration


Dive into the Daniel Bichon's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

P. Soubrié

University of Montpellier

View shared research outputs
Researchain Logo
Decentralizing Knowledge